Technology News and Research

RSS

Ligand Pharmaceuticals announces data from LG-7501 preclinical studies on HCV

Ligand Pharmaceuticals Incorporated announced that data from preclinical studies evaluating LG-7501 were featured in a poster presentation today at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases in Boston.

14 Nov 2012

IDMC reviews data from Nanobiotix’s NBTXR3 Phase I study on advanced soft tissue sarcoma

Nanobiotix, announced today that the Independent Data Monitoring Committee (IDMC) has reviewed the data of the first 6 patients treated in the phase I Study with the lead product NBTXR3 for the treatment of advanced Soft Tissue Sarcoma of the extremity. Based on the review of the safety data, the IDMC has unanimously recommended continuing the enrollment in the study according to the protocol. This trial is realized in the Institut Gustave Roussy, France.

13 Nov 2012

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Implantable defibrillators currently on the market apply between 600 and 900 volts to the heart, almost 10 times the voltage from an electric outlet, says Ajit H. Janardhan, MD, PhD, a cardiac electrophysiology fellow at the Washington University's School of Medicine.

13 Nov 2012

Cancer metastasis research facilitated by nanoparticle characterization technology from NanoSight

NanoSight, leading manufacturers of unique nanoparticle characterization technology, reports on the breakthrough cancer metastasis research of Dr. Hector Peinado Selgas and Dr. David Lyden's research team from Weill Cornell Medical College.

13 Nov 2012

Auto-injector developed for women undergoing fertility treatment

A new auto-injector concept has been designed by innovative product development firm Cambridge Consultants in a bid to ease the trauma for women undergoing fertility treatment.

12 Nov 2012

Automated eye tests best for toddlers

Children under the age of 4 years benefit from instrument-based vision screening rather than visual acuity tests since the former is quick, requires minimal cooperation of the child, and is not dependent on their behavioral responses, says a policy statement released by the American Academy of Pediatrics.

9 Nov 2012

Semprus BioSciences to develop surface-modified endotracheal tube

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced that Semprus BioSciences, a wholly owned subsidiary of Teleflex Incorporated, has been awarded the initial phase of a $2.3 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD.

9 Nov 2012

Boehner, Obama signal willingness to work together on fiscal crisis

The House speaker says he would accept a deal that raises federal revenues, but not the top tax rates, if it also includes an overhaul of entitlement programs, such as Medicare and Medicaid.

9 Nov 2012

Smoking and smartphones: an interview with Nasser Bin Dhim, Becky Freeman and Lyndal Trevena

Australia adopted the WHO Framework Convention on Tobacco Control (WHO FCTC) in 2005. This includes a ban on all forms of tobacco advertising including on the internet.

9 Nov 2012

ACT announces results from three ongoing stem cell clinical trials for macular degeneration

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.

9 Nov 2012

New method can help identify smoke-divers in danger

Smoke-divers are exposed to high temperatures, physical exhaustion and stress, and they can easily exceed the limits of what good health can tolerate. A new method based on measurements made by a wireless sensor system lets them know when the body has had enough.

9 Nov 2012

Teleconcussion for diagnosis and management of mild TBI in athletes

Concussion is a common disorder estimated to affect no fewer than 1.7-3.8 million people in the U.S. each year. Many more people with concussion likely do not seek medical care for symptoms of concussion and may suffer long-lasting, progressive, and profoundcognitive, psychiatric, and neurologic effects.

9 Nov 2012

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Immunomic Therapeutics, Inc., a leader in developing novel allergy immunotherapies, announced today that it has dosed the first patient in a Phase I clinical trial of its lead candidate, JRC-LAMP-vax vaccine, at its clinical site in Honolulu, Hawaii. Initial subjects include Japanese ex-patriates previously exposed to Japanese red cedar, or "Sugi," as it is known in Japan.

9 Nov 2012

Regenstrief Institute and Merck sign five-year collaboration agreement

The Regenstrief Institute and Merck, known as MSD outside the United States and Canada, have signed a five-year agreement to collaborate on a range of projects that will use clinical data to inform personalized delivery of health care.

9 Nov 2012

New England Journal of Medicine publishes BMC's capnography training video

Physicians at Boston Medical Center (BMC) have developed a training video for health care providers about how to effectively use capnography to monitor ventilation and carbon dioxide levels for patients under anesthesia or conscious sedation. This is the sixth video published in the New England Journal of Medicine's Videos in Clinical Medicine section produced by BMC. It highlights the importance of using capnography to increase patient safety.

9 Nov 2012

Avinger receives FDA clearance for Ocelot System

Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for crossing chronic total occlusions (CTOs) in patients with Peripheral Artery Disease (PAD), announces its Ocelot System has been cleared for sale in the U.S. by the Food and Drug Administration (FDA).

9 Nov 2012

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent prostate cancer. Mayo Clinic is the first, and currently only, institution in North America approved to produce this imaging agent.

9 Nov 2012

Pevion launches Defensomes platform for broad spectrum immune enhancement

Pevion Biotech AG today announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied to humans to date. Defensomes offer opportunities for a wide range of prophylactic and therapeutic indications, where boosting of the body's own natural defense is beneficial.

8 Nov 2012

FDA grants Albireo's A4250 orphan-drug designation for treatment of PFIC and PBC

Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).

8 Nov 2012

ACS Prized Science video features advances in personalized medicine

Personalized medicine - the promise of customizing treatments that will work best for each individual patient - could get a boost from advances in understanding how the proteins that help determine health and disease take the three-dimensional shapes needed to work in the body. That's the message of the latest episode of the 2012 edition of a popular video series from the American Chemical Society (ACS), the world's largest scientific society.

8 Nov 2012

Technology News and Research

Ligand Pharmaceuticals announces data from LG-7501 preclinical studies on HCV

IDMC reviews data from Nanobiotix’s NBTXR3 Phase I study on advanced soft tissue sarcoma

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Cancer metastasis research facilitated by nanoparticle characterization technology from NanoSight

Auto-injector developed for women undergoing fertility treatment

Automated eye tests best for toddlers

Semprus BioSciences to develop surface-modified endotracheal tube

Boehner, Obama signal willingness to work together on fiscal crisis

Smoking and smartphones: an interview with Nasser Bin Dhim, Becky Freeman and Lyndal Trevena

ACT announces results from three ongoing stem cell clinical trials for macular degeneration

New method can help identify smoke-divers in danger

Teleconcussion for diagnosis and management of mild TBI in athletes

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Regenstrief Institute and Merck sign five-year collaboration agreement

New England Journal of Medicine publishes BMC's capnography training video

Avinger receives FDA clearance for Ocelot System

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

Pevion launches Defensomes platform for broad spectrum immune enhancement

FDA grants Albireo's A4250 orphan-drug designation for treatment of PFIC and PBC

ACS Prized Science video features advances in personalized medicine

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News